Bone Biologics (BBLG) Assets (2012 - 2026)
Bone Biologics (BBLG) posted quarterly Assets of $5.8 million for Q4 2025, up 50.11% year-over-year from $3.9 million in Q4 2024, and down 8.73% quarter-over-quarter from $6.4 million in Q3 2025.
Powered by 
Analysis
Bone Biologics (BBLG) Assets (2012 - 2026) Analysis & Trends
Bone Biologics (BBLG) has reported Assets for 14 consecutive years, with $5.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Assets rose 50.11% year-over-year to $5.8 million; the TTM figure through Dec 2025 stood at $5.8 million (up 50.11% YoY), while the FY2025 annual figure was $5.8 million, up 50.11% from the prior year.
- Assets eased to $5.8 million in Q4 2025 per BBLG's latest filing, from $6.4 million in the prior quarter.
- Across five years, Assets topped out at $8.5 million in Q4 2022 and bottomed at $4438.0 in Q2 2021.
- Historically, Assets has averaged $4.6 million across 5 years, with a median of $5.1 million in 2022.
- Annual changes were most pronounced in 2022 — Assets jumped 127409.71% — and 2024, when it plunged 58.11%.
- Bone Biologics' Assets stood at $6.7 million in 2021, then advanced by 27.26% to $8.5 million in 2022, then tumbled by 56.0% to $3.7 million in 2023, then gained by 3.31% to $3.9 million in 2024, then jumped by 50.11% to $5.8 million in 2025.
- Business Quant data shows BBLG's Assets at $5.8 million in Q4 2025, $6.4 million in Q3 2025, and $7.0 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 4.32 Bn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 9.18 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 5.56 Bn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 19.82 Bn |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Bone Biologics | 1.00 Mn | 1.00 Mn | - | 4.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.44 Mn |
| Dec 31, 2025 | 5.80 Mn |
| Sep 30, 2025 | 6.35 Mn |
| Jun 30, 2025 | 7.00 Mn |
| Mar 31, 2025 | 3.16 Mn |
| Dec 31, 2024 | 3.86 Mn |
| Sep 30, 2024 | 4.07 Mn |
| Jun 30, 2024 | 3.19 Mn |
| Mar 31, 2024 | 3.84 Mn |
| Dec 31, 2023 | 3.74 Mn |
| Sep 30, 2023 | 4.98 Mn |
| Jun 30, 2023 | 7.62 Mn |
| Mar 31, 2023 | 6.78 Mn |
| Dec 31, 2022 | 8.50 Mn |
| Sep 30, 2022 | 5.20 Mn |
| Jun 30, 2022 | 5.66 Mn |
| Mar 31, 2022 | 6.09 Mn |
| Dec 31, 2021 | 6.68 Mn |
| Sep 30, 2021 | 52,393.00 |
| Jun 30, 2021 | 4,438.00 |